LBT INNOVATIONS LIMITED - Announcements

Market Cap $22.79M Add to my watchlist

Healthcare Medical Devices

LBT Innovations is a ground-breaking designer of advanced technology solutions for the... LBT Innovations is a ground-breaking designer of advanced technology solutions for the medical industry. We specialise in combining artificial intelligence, image analysis and software engineering to improve healthcare delivery. Our product, APAS® Independence, is a global first solution for automated reading of microbiology culture plates.More

Announcements

Filter Results

All Price Sensitive Only

LBT	Notice under Section 708A - Cleansing Notice		26/05/23	86.34KB	Share
LBT	Application for quotation of securities - LBT		26/05/23	24.96KB	Share
LBT	New Company Presentation		12/05/23	1.59MB	Share
LBT	Upcoming Investor Webinar Presentation		10/05/23	102.78KB	Share
LBT	LBT Board - Chair Transition Process		08/05/23	107.09KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	365.77KB	Share
LBT	NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE		19/04/23	243.91KB	Share
LBT	Notification of cessation of securities - LBT		11/04/23	21.69KB	Share
LBT	Director Retirement & Appendix 3Z		30/03/23	253.29KB	Share
LBT	Notice under Section 708A - Cleansing Notice		23/03/23	86.52KB	Share
LBT	Notification regarding unquoted securities - LBT		23/03/23	27.84KB	Share
LBT	Application for quotation of securities - LBT		23/03/23	25.37KB	Share
LBT	Proposed issue of securities - LBT		20/03/23	29.73KB	Share
LBT	Placement Supports APAS Pharma & EU Expansion	PRICE SENSITIVE	20/03/23	174.43KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	1.17MB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/01/23	463.53KB	Share
LBT	LBT Company Presentation		20/01/23	1.03MB	Share
LBT	Quarterly Investor Call		19/01/23	106.85KB	Share
LBT	Notification of cessation of securities - LBT		11/01/23	21.71KB	Share
LBT	AstraZeneca Partners LBT for APAS Pharma Development	PRICE SENSITIVE	09/01/23	117.2KB	Share
LBT	Release from Escrow		03/01/23	86.54KB	Share
LBT	LBT Strengthens APAS Pharma Development	PRICE SENSITIVE	20/12/22	110.44KB	Share
LBT	CCS Appoint Thermo Fisher as Exclusive European Distributor	PRICE SENSITIVE	19/12/22	115.88KB	Share
LBT	Appendix 3Y - all Directors		02/12/22	268.2KB	Share
LBT	Notice under s708A - Cleansing Notice		28/11/22	86.3KB	Share
LBT	Notification regarding unquoted securities - LBT		28/11/22	23.99KB	Share
LBT	Application for quotation of securities - LBT		28/11/22	24.92KB	Share
LBT	Non-renounceable Rights Issue Results	PRICE SENSITIVE	28/11/22	114.71KB	Share
LBT	Application for quotation of securities - LBT		25/11/22	24.83KB	Share
LBT	Entitlement Offer Letters Mailed to Shareholders		01/11/22	346.05KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	456.94KB	Share
LBT	Application for quotation of securities - LBT		31/10/22	25.02KB	Share
LBT	Application for quotation of securities - LBT		26/10/22	24.88KB	Share
LBT	Proposed issue of securities - LBT		26/10/22	24.76KB	Share
LBT	Results of Meeting		26/10/22	154.28KB	Share
LBT	Chair's Address to Shareholders		26/10/22	155.46KB	Share
LBT	CEO Presentation		26/10/22	994.52KB	Share
LBT	LBT Receives $1,206,058 R&D Tax Incentive		25/10/22	134.71KB	Share
LBT	Proposed issue of securities - LBT		25/10/22	33.28KB	Share
LBT	Rights Issue Prospectus	PRICE SENSITIVE	25/10/22	630.34KB	Share
LBT	Non-Renounceable Rights Issue	PRICE SENSITIVE	25/10/22	198.85KB	Share
LBT	$1.5M Funding Awarded for New APAS Instrument	PRICE SENSITIVE	24/10/22	207.89KB	Share
LBT	Notification of cessation of securities - LBT		17/10/22	22.22KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		21/09/22	619.17KB	Share
LBT	BioPhorum Presentation		14/09/22	2.32MB	Share
LBT	APAS Independence Market Update		13/09/22	132.28KB	Share
LBT	Company Presentation ASX Small and Mid-Cap Conference		13/09/22	1020.52KB	Share
LBT	New Data Published on APAS Technology		31/08/22	128.29KB	Share
LBT	Appendix 4G		29/08/22	272.99KB	Share
LBT	Corporate Governance Statement		29/08/22	274.9KB	Share
LBT	Annual Report to shareholders		29/08/22	2.88MB	Share
LBT	Appendix 4E	PRICE SENSITIVE	29/08/22	126.33KB	Share
LBT	Application for quotation of securities - LBT		24/08/22	27.24KB	Share
LBT	Proposed issue of securities - LBT		16/08/22	25.34KB	Share
LBT	Updated Product Pipeline Strategy Announced		10/08/22	440.9KB	Share
LBT	Notification of cessation of securities - LBT		03/08/22	21.64KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	284.83KB	Share
LBT	APAS Independence Showcased at Major US Microbiology Conf		14/06/22	512.95KB	Share
LBT	Direct Sale of APAS Independence in United States	PRICE SENSITIVE	03/05/22	174.44KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	451.86KB	Share
LBT	Clinical Data Featuring APAS Technology Presented at ECCMID		27/04/22	187.44KB	Share
LBT	Purchase Order for Multiple APAS Instruments	PRICE SENSITIVE	16/03/22	154.35KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/22	948.1KB	Share
LBT	LBT Receives $824,500 R&D Tax Incentive		15/02/22	134.36KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/22	357.01KB	Share
LBT	Notification regarding unquoted securities - LBT		13/01/22	27.52KB	Share
LBT	Notification of cessation of securities - LBT		12/01/22	21.58KB	Share
LBT	LBT Investor Call to discuss CCS Acquisition	PRICE SENSITIVE	11/01/22	995.92KB	Share
LBT	LBT Completes CCS Acquisition		04/01/22	208.66KB	Share
LBT	Notice of Initial Substantial Holder		04/01/22	43.88KB	Share
LBT	LBT Completes CCS Acquisition	PRICE SENSITIVE	04/01/22	131.87KB	Share
LBT	Appendix 3Y - Simon Arkell		30/12/21	170.7KB	Share
LBT	Appendix 3Y - Damian Lismore		30/12/21	170.79KB	Share
LBT	Appendix 3Y - Brian O'Dwyer		30/12/21	171.2KB	Share
LBT	Appendix 3Y - Joanne Moss		30/12/21	171.58KB	Share
LBT	Notice under Section 708A - Cleansing Notice		30/12/21	88.08KB	Share
LBT	Notification regarding unquoted securities - LBT		30/12/21	27.68KB	Share
LBT	Application for quotation of securities - LBT		30/12/21	25.05KB	Share
LBT	Update - Proposed issue of securities - LBT		29/12/21	27.98KB	Share
LBT	Notification regarding unquoted securities - LBT		29/12/21	26.11KB	Share
LBT	Notification regarding unquoted securities - LBT		29/12/21	23.72KB	Share
LBT	Application for quotation of securities - LBT		29/12/21	24.76KB	Share
LBT	Proposed issue of securities - LBT		29/12/21	28.15KB	Share
LBT	LBT to Obtain Full Ownership of CCS Joint Venture	PRICE SENSITIVE	29/12/21	146.74KB	Share
LBT	Market Update - Sales Pipeline and Evaluations	PRICE SENSITIVE	08/12/21	163.72KB	Share
LBT	Results of Meeting		30/11/21	163.07KB	Share
LBT	CEO Presentation - AGM 2021		29/11/21	1.18MB	Share
LBT	Chair's Address to Shareholders - AGM 2021		29/11/21	142.79KB	Share
LBT	Jobkeeper Payments Notification		24/11/21	31.45KB	Share
LBT	US FDA 510(k) Clearance for MRSA Analysis Module	PRICE SENSITIVE	29/10/21	335.82KB	Share
LBT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/21	444.4KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		27/10/21	765.55KB	Share
LBT	Presentation at Australia Biotech Invest & Partnering 2021		26/10/21	1.36MB	Share
LBT	SA Government Extends Loan Repayment Schedule		08/10/21	159.54KB	Share
LBT	Final Director's Interest Notice		01/10/21	264.87KB	Share
LBT	Kate Costello Retires as Director and Chair of the Board		30/09/21	141.83KB	Share
LBT	Appendix 4G		30/09/21	302.12KB	Share
LBT	Corporate Governance Statement		30/09/21	281.89KB	Share
LBT	Annual Report to shareholders		29/09/21	3.35MB	Share
LBT	Initial Director's Interest Notice		28/09/21	215.9KB	Share

LBT Notice under Section 708A - Cleansing Notice
26/05/23		86.34KB	Share
LBT Application for quotation of securities - LBT
26/05/23		24.96KB	Share
LBT New Company Presentation
12/05/23		1.59MB	Share
LBT Upcoming Investor Webinar Presentation
10/05/23		102.78KB	Share
LBT LBT Board - Chair Transition Process
08/05/23		107.09KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	365.77KB	Share
LBT NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE
19/04/23		243.91KB	Share
LBT Notification of cessation of securities - LBT
11/04/23		21.69KB	Share
LBT Director Retirement & Appendix 3Z
30/03/23		253.29KB	Share
LBT Notice under Section 708A - Cleansing Notice
23/03/23		86.52KB	Share
LBT Notification regarding unquoted securities - LBT
23/03/23		27.84KB	Share
LBT Application for quotation of securities - LBT
23/03/23		25.37KB	Share
LBT Proposed issue of securities - LBT
20/03/23		29.73KB	Share
LBT Placement Supports APAS Pharma & EU Expansion
20/03/23	PRICE SENSITIVE	174.43KB	Share
LBT Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	1.17MB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
23/01/23	PRICE SENSITIVE	463.53KB	Share
LBT LBT Company Presentation
20/01/23		1.03MB	Share
LBT Quarterly Investor Call
19/01/23		106.85KB	Share
LBT Notification of cessation of securities - LBT
11/01/23		21.71KB	Share
LBT AstraZeneca Partners LBT for APAS Pharma Development
09/01/23	PRICE SENSITIVE	117.2KB	Share
LBT Release from Escrow
03/01/23		86.54KB	Share
LBT LBT Strengthens APAS Pharma Development
20/12/22	PRICE SENSITIVE	110.44KB	Share
LBT CCS Appoint Thermo Fisher as Exclusive European Distributor
19/12/22	PRICE SENSITIVE	115.88KB	Share
LBT Appendix 3Y - all Directors
02/12/22		268.2KB	Share
LBT Notice under s708A - Cleansing Notice
28/11/22		86.3KB	Share
LBT Notification regarding unquoted securities - LBT
28/11/22		23.99KB	Share
LBT Application for quotation of securities - LBT
28/11/22		24.92KB	Share
LBT Non-renounceable Rights Issue Results
28/11/22	PRICE SENSITIVE	114.71KB	Share
LBT Application for quotation of securities - LBT
25/11/22		24.83KB	Share
LBT Entitlement Offer Letters Mailed to Shareholders
01/11/22		346.05KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	456.94KB	Share
LBT Application for quotation of securities - LBT
31/10/22		25.02KB	Share
LBT Application for quotation of securities - LBT
26/10/22		24.88KB	Share
LBT Proposed issue of securities - LBT
26/10/22		24.76KB	Share
LBT Results of Meeting
26/10/22		154.28KB	Share
LBT Chair's Address to Shareholders
26/10/22		155.46KB	Share
LBT CEO Presentation
26/10/22		994.52KB	Share
LBT LBT Receives $1,206,058 R&D Tax Incentive
25/10/22		134.71KB	Share
LBT Proposed issue of securities - LBT
25/10/22		33.28KB	Share
LBT Rights Issue Prospectus
25/10/22	PRICE SENSITIVE	630.34KB	Share
LBT Non-Renounceable Rights Issue
25/10/22	PRICE SENSITIVE	198.85KB	Share
LBT $1.5M Funding Awarded for New APAS Instrument
24/10/22	PRICE SENSITIVE	207.89KB	Share
LBT Notification of cessation of securities - LBT
17/10/22		22.22KB	Share
LBT Notice of Annual General Meeting/Proxy Form
21/09/22		619.17KB	Share
LBT BioPhorum Presentation
14/09/22		2.32MB	Share
LBT APAS Independence Market Update
13/09/22		132.28KB	Share
LBT Company Presentation ASX Small and Mid-Cap Conference
13/09/22		1020.52KB	Share
LBT New Data Published on APAS Technology
31/08/22		128.29KB	Share
LBT Appendix 4G
29/08/22		272.99KB	Share
LBT Corporate Governance Statement
29/08/22		274.9KB	Share
LBT Annual Report to shareholders
29/08/22		2.88MB	Share
LBT Appendix 4E
29/08/22	PRICE SENSITIVE	126.33KB	Share
LBT Application for quotation of securities - LBT
24/08/22		27.24KB	Share
LBT Proposed issue of securities - LBT
16/08/22		25.34KB	Share
LBT Updated Product Pipeline Strategy Announced
10/08/22		440.9KB	Share
LBT Notification of cessation of securities - LBT
03/08/22		21.64KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	284.83KB	Share
LBT APAS Independence Showcased at Major US Microbiology Conf
14/06/22		512.95KB	Share
LBT Direct Sale of APAS Independence in United States
03/05/22	PRICE SENSITIVE	174.44KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	451.86KB	Share
LBT Clinical Data Featuring APAS Technology Presented at ECCMID
27/04/22		187.44KB	Share
LBT Purchase Order for Multiple APAS Instruments
16/03/22	PRICE SENSITIVE	154.35KB	Share
LBT Half Yearly Report and Accounts
25/02/22	PRICE SENSITIVE	948.1KB	Share
LBT LBT Receives $824,500 R&D Tax Incentive
15/02/22		134.36KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22	PRICE SENSITIVE	357.01KB	Share
LBT Notification regarding unquoted securities - LBT
13/01/22		27.52KB	Share
LBT Notification of cessation of securities - LBT
12/01/22		21.58KB	Share
LBT LBT Investor Call to discuss CCS Acquisition
11/01/22	PRICE SENSITIVE	995.92KB	Share
LBT LBT Completes CCS Acquisition
04/01/22		208.66KB	Share
LBT Notice of Initial Substantial Holder
04/01/22		43.88KB	Share
LBT LBT Completes CCS Acquisition
04/01/22	PRICE SENSITIVE	131.87KB	Share
LBT Appendix 3Y - Simon Arkell
30/12/21		170.7KB	Share
LBT Appendix 3Y - Damian Lismore
30/12/21		170.79KB	Share
LBT Appendix 3Y - Brian O'Dwyer
30/12/21		171.2KB	Share
LBT Appendix 3Y - Joanne Moss
30/12/21		171.58KB	Share
LBT Notice under Section 708A - Cleansing Notice
30/12/21		88.08KB	Share
LBT Notification regarding unquoted securities - LBT
30/12/21		27.68KB	Share
LBT Application for quotation of securities - LBT
30/12/21		25.05KB	Share
LBT Update - Proposed issue of securities - LBT
29/12/21		27.98KB	Share
LBT Notification regarding unquoted securities - LBT
29/12/21		26.11KB	Share
LBT Notification regarding unquoted securities - LBT
29/12/21		23.72KB	Share
LBT Application for quotation of securities - LBT
29/12/21		24.76KB	Share
LBT Proposed issue of securities - LBT
29/12/21		28.15KB	Share
LBT LBT to Obtain Full Ownership of CCS Joint Venture
29/12/21	PRICE SENSITIVE	146.74KB	Share
LBT Market Update - Sales Pipeline and Evaluations
08/12/21	PRICE SENSITIVE	163.72KB	Share
LBT Results of Meeting
30/11/21		163.07KB	Share
LBT CEO Presentation - AGM 2021
29/11/21		1.18MB	Share
LBT Chair's Address to Shareholders - AGM 2021
29/11/21		142.79KB	Share
LBT Jobkeeper Payments Notification
24/11/21		31.45KB	Share
LBT US FDA 510(k) Clearance for MRSA Analysis Module
29/10/21	PRICE SENSITIVE	335.82KB	Share
LBT Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21	PRICE SENSITIVE	444.4KB	Share
LBT Notice of Annual General Meeting/Proxy Form
27/10/21		765.55KB	Share
LBT Presentation at Australia Biotech Invest & Partnering 2021
26/10/21		1.36MB	Share
LBT SA Government Extends Loan Repayment Schedule
08/10/21		159.54KB	Share
LBT Final Director's Interest Notice
01/10/21		264.87KB	Share
LBT Kate Costello Retires as Director and Chair of the Board
30/09/21		141.83KB	Share
LBT Appendix 4G
30/09/21		302.12KB	Share
LBT Corporate Governance Statement
30/09/21		281.89KB	Share
LBT Annual Report to shareholders
29/09/21		3.35MB	Share
LBT Initial Director's Interest Notice
28/09/21		215.9KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 1.7¢		Change 0.000(0.00%)		Mkt cap ! $22.79M

Open	High	Low	Value	Volume
1.7¢	1.8¢	1.7¢	$10.24K	600K

Buyers (Bids)

No.	Vol.	Price($)
4	872390	1.7¢

Sellers (Offers)

Price($)	Vol.	No.
1.8¢	100000	1

View Market Depth

No.	Vol.	Price($)
4	872390	0.017
2	1080000	0.016
2	75000	0.015
2	136428	0.014
3	509999	0.013

Price($)	Vol.	No.
0.018	100000	1
0.019	52000	1
0.020	475642	3
0.021	350000	5
0.023	64488	1

Last trade - 11.06am 15/05/2024 (20 minute delay)


Last 1.7¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
1.8¢	1.8¢	1.7¢	471980
Last updated 11.06am 15/05/2024 ?

LBT (ASX) Chart

LBT INNOVATIONS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories